Last reviewed · How we verify

keto-analogs — Competitive Intelligence Brief

keto-analogs (keto-analogs) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Ketone body analog. Area: Diabetes.

phase 3 Ketone body analog Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

keto-analogs (keto-analogs) — Hospices Civils de Lyon. Keto-analogs are synthetic compounds that mimic the effects of ketone bodies, which are produced by the liver when it breaks down fat for energy.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
keto-analogs TARGET keto-analogs Hospices Civils de Lyon phase 3 Ketone body analog

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Ketone body analog class)

  1. Hospices Civils de Lyon · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). keto-analogs — Competitive Intelligence Brief. https://druglandscape.com/ci/keto-analogs. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing